SE0004462D0 - Novel method and use - Google Patents

Novel method and use

Info

Publication number: SE0004462D0
Authority: SE; Sweden
Prior art keywords: alkoxy; hydroxy; compound; relates; novel method
Prior art date: 2000-12-04

Application number

SE0004462A

Other languages

English (en)

Inventor

Alvar Groenberg

Jerry R Colca

Original Assignee

Pharmacia Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-04

Filing date

2000-12-04

Publication date

2000-12-04

2000-12-04 Application filed by Pharmacia Ab filed Critical Pharmacia Ab

2000-12-04 Priority to SE0004462A priority Critical patent/SE0004462D0/sv

2000-12-04 Publication of SE0004462D0 publication Critical patent/SE0004462D0/sv

2001-12-03 Priority to US10/006,518 priority patent/US6573291B2/en

2001-12-04 Priority to AU2002221222A priority patent/AU2002221222A1/en

2001-12-04 Priority to PCT/SE2001/002680 priority patent/WO2002045712A1/en

Links

125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
102100025101 GATA-type zinc finger protein 1 Human genes 0.000 abstract 1
101710198884 GATA-type zinc finger protein 1 Proteins 0.000 abstract 1
DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 abstract 1
230000003042 antagnostic effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical group 0.000 abstract 1
150000002431 hydrogen Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

SE0004462A 2000-12-04 2000-12-04 Novel method and use SE0004462D0 (sv)

Priority Applications (4)

Application Number	Priority Date	Filing Date	Title
SE0004462A SE0004462D0 (sv)	2000-12-04	2000-12-04	Novel method and use
US10/006,518 US6573291B2 (en)	2000-12-04	2001-12-03	Method and use
AU2002221222A AU2002221222A1 (en)	2000-12-04	2001-12-04	Novel method and use
PCT/SE2001/002680 WO2002045712A1 (en)	2000-12-04	2001-12-04	Novel method and use

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0004462A SE0004462D0 (sv)	2000-12-04	2000-12-04	Novel method and use

Publications (1)

Publication Number	Publication Date
SE0004462D0 true SE0004462D0 (sv)	2000-12-04

Family

ID=20282078

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE0004462A SE0004462D0 (sv)	2000-12-04	2000-12-04	Novel method and use

Country Status (2)

Country	Link
US (1)	US6573291B2 (sv)
SE (1)	SE0004462D0 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002066062A2 (en) *	2001-02-01	2002-08-29	Drucker Daniel J	Enhancement of glp-2 activity
WO2003087399A1 (en) *	2002-04-17	2003-10-23	Glucox Ab	Nad)p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes
WO2004103310A2 (en) *	2003-05-20	2004-12-02	New England Medical Center Hospitals, Inc.	Methods and compositions for the treatment of metabolic disorders
HRP20220346T3 (hr)	2007-01-08	2022-09-02	The Trustees Of The University Of Pennsylvania	Antagonist glp-1 receptora za upotrebu u liječenju kongenitalnog hiperinzulinizma
US11311519B2 (en)	2014-05-01	2022-04-26	Eiger Biopharmaceuticals, Inc.	Treatment of hepatitis delta virus infection
PL3297654T3 (pl)	2015-05-22	2021-12-20	The Board Of Trustees Of The Leland Stanford Junior University	Leczenie pobariatrycznej hipoglikemii eksendyną (9-39)
US10653753B2 (en)	2016-03-04	2020-05-19	Eiger Biopharmaceuticals, Inc.	Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives
SI3541366T1 (sl)	2016-11-21	2025-05-30	Amylyx Pharmaceuticals, Inc.	Zapufrane formulacije eksendina (9-39)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4539325A (en)	1983-11-07	1985-09-03	Janssen Pharmaceutica N.V.	1-(2-Aryl-2-halo-1-ethenyl)-1H-azoles, and anticonvulsant use thereof
JPH06510760A (ja)	1991-08-27	1994-12-01	ジ・アップジョン・カンパニー	代謝障害および代謝の治療法
EP1177188B1 (en) *	1999-05-12	2005-10-12	Ortho-McNeil Pharmaceutical, Inc.	Pyrazole carboxamides useful for the treatment of obesity and other disorders

2000
- 2000-12-04 SE SE0004462A patent/SE0004462D0/sv unknown
2001
- 2001-12-03 US US10/006,518 patent/US6573291B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20020107277A1 (en)	2002-08-08
US6573291B2 (en)	2003-06-03

Similar Documents

Publication	Publication Date	Title
BG106095A (bg)	2002-06-28	Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
GB9914486D0 (en)	1999-08-18	Medicaments
CY1107850T1 (el)	2013-06-19	Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
SE0001899D0 (sv)	2000-05-22	New compounds
DE69533174D1 (de)	2004-07-22	Pyridopyrimidinone, chinoline und anellierte n-heterozyklen als bradykinin-antagonisten
ATE306261T1 (de)	2005-10-15	Antithrombosemittel
AU2003301020A1 (en)	2004-07-22	Isoquinolinone derivatives and their use as therapeutic agents
HUP0400365A2 (hu)	2004-08-30	3-Fluor-pirrolidinek, mint cukorbetegség elleni szerek és a vegyületeket tartalmazó gyógyszerkészítmények
JO2475B1 (en)	2009-01-20	Glucokinase stimulants
IL133623A0 (en)	2001-04-30	Antithrombotic agents
BR9713552A (pt)	2000-01-25	Derivados de pirimidina bicìclicos condensados
MX2007000028A (es)	2007-07-20	Derivados de nicotinamida y su uso como agentes terapeuticos.
BR0108173A (pt)	2003-01-21	Composições farmacêuticas de toxina de botulina
MY127718A (en)	2006-12-29	Dolastatin 10 derivatives.
BR0114257A (pt)	2003-07-01	Ligandos de receptores de melanocortina
ATE433959T1 (de)	2009-07-15	Analoge von kokain
IL147852A0 (en)	2002-08-14	Chemokine receptor antagonists and pharmaceutical compositions containing the same
IL137266A0 (en)	2001-07-24	Heterocyclic chemokine receptor antagonists and pharmaceutical compositions containing the same
ATE495187T1 (de)	2011-01-15	Dalda-analoge und ihre verwendung
SE9802206D0 (sv)	1998-06-22	Novel compounds
WO1999026932A8 (en)	1999-09-10	By amidino group substituted heterocyclic derivatives and their use as anticoagulants
SE0102440D0 (sv)	2001-07-05	New compound
SE0004462D0 (sv)	2000-12-04	Novel method and use
GEP20043227B (en)	2004-04-26	5HT1 Antagonists for Antidepressant Therapy
EP1019047A4 (en)	2001-06-13	ANTITHROMBOTIC AGENTS